Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tian-Li Wang

Showing results (1-10 of 222) with videos related to

Pageof 23
Sort By:
Cell|September 6, 2024
Harnessing immune cells to leverage PARP inhibitorsTian-Li Wang, Ie-Ming Shih
Current Opinion in Oncology|December 21, 2004
Apply innovative technologies to explore cancer genomeIe-Ming Shih, Tian-Li Wang
Cancer Research|March 3, 2007
Notch signaling, gamma-secretase inhibitors, and cancer therapyIe-Ming Shih, Tian-Li Wang
The Journal of Pathology|March 25, 2011
Mutation of PPP2R1A: a new clue in unveiling the pathogenesis of uterine serous carcinomaIe-Ming Shih, Tian-Li Wang
Cancer Research|September 9, 2011
ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancersBin Guan, Tian-Li Wang, Ie-Ming Shih
Journal of the National Cancer Institute|December 28, 2017
Precancerous Lesions of Ovarian Cancer-A US PerspectiveKala Visvanathan, Tian-Li Wang, Ie-Ming Shih
International Journal of Molecular Sciences|December 4, 2012
The role of forkhead box Q1 transcription factor in ovarian epithelial carcinomasMin Gao, Ie-Ming Shih, Tian-Li Wang
Human Pathology|July 29, 2008
Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinomaBen Davidson, Ie-Ming Shih, Tian-Li Wang
The American Journal of Pathology|October 4, 2020
The Origin of Ovarian Cancer Species and Precancerous LandscapeIe-Ming Shih, Yeh Wang, Tian-Li Wang
Genes & Diseases|January 26, 2024
The impact of broad glutamine metabolism inhibition on the tumor microenvironmentTianhe Li, Yun-Ta Chuang, Tian-Li Wang
Pageof 23

Showing results (1-10 of 222) with videos related to

Sort By:
Pageof 23
Cell|September 6, 2024
Harnessing immune cells to leverage PARP inhibitorsTian-Li Wang, Ie-Ming Shih
Current Opinion in Oncology|December 21, 2004
Apply innovative technologies to explore cancer genomeIe-Ming Shih, Tian-Li Wang
Cancer Research|March 3, 2007
Notch signaling, gamma-secretase inhibitors, and cancer therapyIe-Ming Shih, Tian-Li Wang
The Journal of Pathology|March 25, 2011
Mutation of PPP2R1A: a new clue in unveiling the pathogenesis of uterine serous carcinomaIe-Ming Shih, Tian-Li Wang
Cancer Research|September 9, 2011
ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancersBin Guan, Tian-Li Wang, Ie-Ming Shih
Journal of the National Cancer Institute|December 28, 2017
Precancerous Lesions of Ovarian Cancer-A US PerspectiveKala Visvanathan, Tian-Li Wang, Ie-Ming Shih
International Journal of Molecular Sciences|December 4, 2012
The role of forkhead box Q1 transcription factor in ovarian epithelial carcinomasMin Gao, Ie-Ming Shih, Tian-Li Wang
Human Pathology|July 29, 2008
Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinomaBen Davidson, Ie-Ming Shih, Tian-Li Wang
The American Journal of Pathology|October 4, 2020
The Origin of Ovarian Cancer Species and Precancerous LandscapeIe-Ming Shih, Yeh Wang, Tian-Li Wang
Genes & Diseases|January 26, 2024
The impact of broad glutamine metabolism inhibition on the tumor microenvironmentTianhe Li, Yun-Ta Chuang, Tian-Li Wang
Pageof 23